Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CYRX declined for three days, in of 288 cases, the price declined further within the following month. The odds of a continued downward trend are .
The 10-day RSI Indicator for CYRX moved out of overbought territory on December 05, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where CYRX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
CYRX broke above its upper Bollinger Band on December 04, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on November 08, 2023. You may want to consider a long position or call options on CYRX as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CYRX just turned positive on November 06, 2023. Looking at past instances where CYRX's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
CYRX moved above its 50-day moving average on November 14, 2023 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CYRX crossed bullishly above the 50-day moving average on November 20, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CYRX advanced for three days, in of 323 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 223 cases where CYRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CYRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.349) is normal, around the industry mean (17.349). P/E Ratio (0.000) is within average values for comparable stocks, (22.905). CYRX's Projected Growth (PEG Ratio) (62.128) is very high in comparison to the industry average of (11.069). CYRX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.043). CYRX's P/S Ratio (2.909) is slightly higher than the industry average of (1.200).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of cryogenic logistics solutions to the life sciences industry
|MFs / NAME||Price $||Chg $||Chg %|
|Morgan Stanley Instl US Core I|
|Artisan Select Equity Institutional|
|Jensen Quality Growth J|
|Janus Henderson Mid Cap Value R|
|American Beacon Stephens Mid-Cap Gr A|
A.I.dvisor indicates that over the last year, CYRX has been loosely correlated with XPO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CYRX jumps, then XPO could also see price increases.